AzTrials
AzTrials

Artificial IntelligenceNCT05369572

Connection Between Tongue Signs and Bile Reflux Analysed With Artificial Intelligence

An observational study of Artificial Intelligence and Tongue, run by Shandong University at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

By introducing artificial intelligence into Chinese medicine tongue diagnosis, we collated and collected tongue images, anxiety and depression scales and gastroscopy reports, mined and analysed the correlation between tongue images and bile reflux and anxiety and depression and constructed a prediction model to… Read more about this study

Who is it for?
Ages 18 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Artificial Intelligence, Tongue, Bile Reflux
How many people
1,500 participants
Where
1 siteChina
Study dates
30 Jun 2022to 30 Jun 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Patients aged 18-80 years who will undergo gastroscopy and who fulfil the inclusion criteria and do not fulfil the exclusion criteria.

Who may be able to join

  • Patients aged 18 to 80 years who wish to undergo gastroscopy.
  • Patients have given their informed consent and signed the informed consent form.

Who cannot join

  • Serious heart, liver, kidney or other underlying illness, or mental illness.
  • Patients taking anti-anxiety or depression medication within 3 months.
  • Current H. pylori infection.
  • History of surgery on the digestive or biliary tract.
  • Peptic ulcer, malignant tumour of the digestive tract, etc.
  • Patients taking bismuth or other staining medications.
  • Pregnant or lactating women.

Trial locations and contacts

1 site in 1 country.

China1 site
  • Qilu hosipital

    Jinan, Shandong, 250012

Other trials in China

About this study

Official title: Analysing the Link Between Tongue Signs and Bile Reflux by Artificial Intelligence

By introducing artificial intelligence into Chinese medicine tongue diagnosis, we collated and collected tongue images, anxiety and depression scales and gastroscopy reports, mined and analysed the correlation between tongue images and bile reflux and anxiety and depression and constructed a prediction model to analyse the possibility of predicting bile reflux and anxiety and depression in patients based on tongue images.

Read the detailed description

Firstly, after the patient signs the informed consent form, the researcher will collect pictures of the patient's tongue and obtain basic information about the patient.

Second, the patients are scored on the Anxiety and Depression Scale.

Thirdly, after the patient undergoes gastroscopy, the patient's gastroscopy report is obtained.

Finally, the patient's tongue image, information and gastroscopy report are matched to construct an artificial intelligence model of tongue image and bile reflux and anxiety and depression, and the quality of the model is assessed.

Keywords
artificial intelligence, tongue, bile reflux
Medical subject headings
Bile Reflux

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT05369572
Study groupRoleWhat they receive
Bile Reflux GroupGastroscopic reports of enrolled patients will be extracted and patients will be identified as having bile reflux according to Kellosalo J classification. Grade I: small amount of yellowish reflux emerging from the pyloric orifice and/or yellowish staining of the mucus lake, which is pale yellow in colour. Grade II: intermittent gush of reflux from the pyloric opening and/or yellowish staining of the mucus lake, which is dark yellow. Grade III: frequent gush of yellow-green reflux from the pyloric orifice and/or yellow-green mucus covering the stomach.
Non-biliary reflux groupGastroscopic reports will be extracted from patients enrolled in the group that do not meet the Kellosalo J classification as the non-biliary reflux group.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sensitivity

    Sensitivity of artificial intelligence models Sensitivity = number of true positives / (number of true positives + number of false negatives) * 100%.

    Measured: 3 years

  2. Specificity

    Specificity of Artificial Intelligence Models Specificity = number of true negatives / (number of true negatives + number of false positives))

    *100%

    Measured: 3 years

  3. Positive predictive values(PPV)

    Positive predictive values from artificial intelligence models Positive predictive value = true positive / (true positive + false positive) *100%

    Measured: 3 years

  4. Negative predictive values (NPV)

    Negative predictive values for artificial intelligence models Negative Predictive Value = True Negative / (True Negative + False Negative) *100%

    Measured: 3 years

  5. AUC (95% CI)

    area under the receiver operating characteristic curve (AUC),

    Measured: 3 years

  6. Accuracy

    Accuracy for artificial intelligence models Accuracy = (true positives + true negatives) / total number of subjects * 100%

    Measured: 3 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 May 2022
  2. Study start30 Jun 2022 (estimated)
  3. Primary completion30 Jun 2024 (estimated)
  4. Study completion30 Jun 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
1,500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05369572
Sponsor's protocol ID
2022SDU-QILU-G002
Status last verified
Jun 2022
First submitted
5 May 2022
Last updated
22 Jun 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Artificial Intelligence and Tongue, run by Shandong University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 22 Jun 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Xiuli Zuo, MD, PhD (86 15588818685 ext. 0531-88369277, zuoxiuli@sdu.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sensitivity (time frame: 3 years). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jun 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in